Elevated plasma levels of vasoactive intestinal peptide in AIDS patients with refractory idiopathic diarrhoea. Effects of treatment with octreotide
作者:
Roberto Manfredi,
Paolo Vezzadini,
Paolo Costigliola,
Ennio Ricchi,
Maria Fanti,
Francesco Chiodo,
期刊:
AIDS
(OVID Available online 1993)
卷期:
Volume 7,
issue 2
页码: 223-226
ISSN:0269-9370
年代: 1993
出版商: OVID
关键词: Idiopathic diarrhoea;vasoactive intestinal peptide;treatment;octreotide;AIDS
数据来源: OVID
摘要:
ObjectiveTo evaluate plasma levels of vasoactive intestinal peptide (VIP) in AIDS patients with refractory idiopathic diarrhoea, and to assess the role of treatment with octreotide.PatientsThree AIDS patients were evaluated for severe watery diarrhoea of 2–6 months' duration, which was complicated by weight loss, weakness, and fluid and electrolyte abnormalities. They had not shown a significant response to several regimens of empirical antimicrobial chemotherapy, or symptomatic antidiarrhoeal treatment.MethodsA complete diagnostic examination, including repeated microbiological evaluation and radiological, ultrasonographic, endoscopic and histological examination, was performed. Plasma levels of VIP were determined by radioimmunoassay and compared with concentrations in a group of healthy subjects.ResultsSince no clinically significant results were obtained from standard diagnostic evaluation and empirical therapeutical attempts, idiopathic refractory diarrhoea was diagnosed. Plasma concentrations of VIP were moderately elevated in all three subjects examined, with levels of 11.5, 17.5 and 9.5pmol/l (values < 8.8pmol/l in the control group). One patient received 50–100 μg octreotide three times daily subcutaneously for 6 months, resulting in complete resolution of diarrhoea and significant improvement in body weight and quality of life, together with a reduction in VIP concentration to within normal values.ConclusionsAlthough the somatostatin analogue octreotide has been used successfully in the management of both infectious and non-infectious AIDS-related diarrhoea, gastrointestinal neuroendocrine function and circulating humoral mediators of diarrhoea have not hitherto been investigated extensively in HIV-infected subjects. Our data on the association of idiopathic secretory diarrhoea and elevated plasma VIP levels provide a possible pathophysiological rationale for identifying AIDS patients whose refractory diarrhoea may be more responsive to octreotide treatment.
点击下载:
PDF
(368KB)
返 回